Revolution Medicines, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Cislini Jeff | General Counsel | Sale | 2,688 | $76.82 | $206,492 | 47,884 | Dec 16, 2025 |
| GOLDSMITH MARK A | See Remarks | Sale | 15,394 | $76.82 | $1,182,567 | 232,469 | Dec 16, 2025 |
| Kelsey Stephen Michael | See Remarks | Sale | 5,447 | $76.82 | $418,439 | 278,600 | Dec 16, 2025 |
| Horn Margaret A | Chief Operating Officer | Sale | 4,847 | $76.82 | $372,347 | 141,053 | Dec 16, 2025 |
| Anders Jack | Chief Financial Officer | Sale | 3,104 | $77.09 | $239,287 | 108,065 | Dec 16, 2025 |
| Anders Jack | Chief Financial Officer | Sale | 5,418 | $74.00 | $400,932 | 110,994 | Nov 25, 2025 |
| GOLDSMITH MARK A | See Remarks | Sale | 3,000 | $75.00 | $225,000 | 67,424 | Nov 25, 2025 |
| GOLDSMITH MARK A | See Remarks | Option Exercise | 20,000 | $4.09 | $81,800 | 267,863 | Nov 18, 2025 |
| Cislini Jeff | General Counsel | Sale | 13,388 | $70.14 | $939,034 | 50,425 | Nov 18, 2025 |
| GOLDSMITH MARK A | See Remarks | Option Exercise | 20,000 | $4.09 | $81,800 | 267,863 | Nov 12, 2025 |
| GOLDSMITH MARK A | See Remarks | Option Exercise | 3,521 | $4.09 | $14,401 | 377,863 | Nov 12, 2025 |
| Anders Jack | Chief Financial Officer | Option Exercise | 10,000 | $17.00 | $170,000 | 120,994 | Nov 11, 2025 |
| Cislini Jeff | General Counsel | Sale | 12,000 | $55.00 | $660,000 | 50,425 | Oct 17, 2025 |
| GOLDSMITH MARK A | See Remarks | Sale | 10,000 | $50.47 | $504,700 | 452,309 | Oct 16, 2025 |
| Kelsey Stephen Michael | See Remarks | Option Exercise | 25,000 | $4.73 | $118,250 | 309,047 | Oct 13, 2025 |
| Cislini Jeff | General Counsel | Sale | 1,799 | $44.26 | $79,624 | 50,425 | Sep 24, 2025 |
| Wei Lin | Chief Medical Officer | Sale | 2,160 | $45.82 | $98,971 | 88,339 | Sep 16, 2025 |
| Kelsey Stephen Michael | See Remarks | Sale | 5,367 | $45.82 | $245,916 | 284,047 | Sep 16, 2025 |
| GOLDSMITH MARK A | See Remarks | Sale | 13,411 | $45.82 | $614,492 | 452,309 | Sep 16, 2025 |
| Horn Margaret A | Chief Operating Officer | Sale | 4,775 | $45.82 | $218,791 | 145,900 | Sep 16, 2025 |
| Cislini Jeff | General Counsel | Sale | 1,869 | $45.82 | $85,638 | 52,224 | Sep 16, 2025 |
| Anders Jack | Chief Financial Officer | Sale | 2,320 | $45.82 | $106,302 | 110,994 | Sep 16, 2025 |
| Kelsey Stephen Michael | See Remarks | Option Exercise | 100,000 | $4.73 | $473,000 | 389,414 | Sep 15, 2025 |
| Anders Jack | Chief Financial Officer | Option Exercise | 3,189 | $4.73 | $15,084 | 116,503 | Sep 3, 2025 |
| GOLDSMITH MARK A | See Remarks | Option Exercise | 37,000 | $0.54 | $19,980 | 465,720 | Jun 30, 2025 |
| Horning Sandra | — | Award / Grant | 3,142 | — | — | 96,574 | Jun 26, 2025 |
| Patel Sushil | — | Award / Grant | 3,142 | — | — | 23,090 | Jun 26, 2025 |
| Kim Lorence H. | — | Award / Grant | 3,142 | — | — | 73,090 | Jun 26, 2025 |
| Borisy Alexis | — | Award / Grant | 3,142 | — | — | 2,338,884 | Jun 26, 2025 |
| Borellini Flavia | — | Award / Grant | 3,142 | — | — | 25,024 | Jun 26, 2025 |
| ANDERSON ELIZABETH M | — | Award / Grant | 3,142 | — | — | 23,215 | Jun 26, 2025 |
| Clyburn Frank | — | Award / Grant | 2,806 | — | — | 9,738 | Jun 26, 2025 |
| Cislini Jeff | General Counsel | Sale | 1,912 | $39.61 | $75,734 | 54,093 | Jun 20, 2025 |
| Horn Margaret A | Chief Operating Officer | Sale | 3,510 | $39.83 | $139,803 | 150,675 | Jun 16, 2025 |
| GOLDSMITH MARK A | See Remarks | Sale | 13,496 | $39.83 | $537,546 | 428,720 | Jun 16, 2025 |
| Cislini Jeff | General Counsel | Sale | 1,878 | $39.83 | $74,801 | 56,005 | Jun 16, 2025 |
| Anders Jack | Chief Financial Officer | Sale | 2,170 | $39.83 | $86,431 | 113,314 | Jun 16, 2025 |
| Kelsey Stephen Michael | See Remarks | Sale | 4,289 | $39.83 | $170,831 | 289,414 | Jun 16, 2025 |
| Wei Lin | Chief Medical Officer | Sale | 2,173 | $39.83 | $86,551 | 90,499 | Jun 16, 2025 |
| Cislini Jeff | General Counsel | Sale | 2,041 | $38.71 | $79,007 | 57,723 | Mar 20, 2025 |
| Cislini Jeff | General Counsel | Sale | 1,458 | $39.04 | $56,920 | 59,764 | Mar 17, 2025 |
| GOLDSMITH MARK A | See Remarks | Sale | 11,738 | $39.04 | $458,252 | 441,564 | Mar 17, 2025 |
| Anders Jack | Chief Financial Officer | Sale | 1,864 | $39.04 | $72,771 | 115,006 | Mar 17, 2025 |
| Horn Margaret A | Chief Operating Officer | Sale | 3,058 | $39.04 | $119,384 | 153,533 | Mar 17, 2025 |
| Kelsey Stephen Michael | See Remarks | Sale | 3,294 | $39.04 | $128,598 | 293,051 | Mar 17, 2025 |
| Wang Xiaolin | See Remarks | Gift | 2,718 | — | — | 102,321 | Mar 17, 2025 |
| Cislini Jeff | General Counsel | Award / Grant | 22,000 | — | — | 61,222 | Mar 1, 2025 |
| Anders Jack | Chief Financial Officer | Award / Grant | 20,400 | — | — | 116,870 | Mar 1, 2025 |
| Kelsey Stephen Michael | See Remarks | Award / Grant | 36,600 | — | — | 296,345 | Mar 1, 2025 |
| Horn Margaret A | Chief Operating Officer | Award / Grant | 28,600 | — | — | 156,591 | Mar 1, 2025 |